rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Nicholas Augustinos

Director

Company insider

Files Form 4 as: Director, DexCom.

In numbers

Trades disclosed
79
Buys
0
Sells
21
Bought
$0
Sold
$13.7M
Companies
1
Companies where not an officer
1
First trade
20 Nov 2009
Last trade
15 Sep 2026
Last filed
16 Sep 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
DXCM DexComDirector · Medical Devices · last 15 Sep 20260 buys · 21 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
20Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
15 Sep 2026filed 16 Sep 2026DXCM DexComMedical DevicesSEC FORM 4 Sold$550K6,539 at $84.04filing
15 Sep 2026filed 16 Sep 2026DXCM DexComMedical DevicesSEC FORM 4 Sold$550K6,539 at $84.04filing
14 Sep 2026filed 16 Sep 2026DXCM DexComMedical DevicesSEC FORM 4 Sold$130K1,550 at $84.02filing
14 Sep 2026filed 16 Sep 2026DXCM DexComMedical DevicesSEC FORM 4 Sold$130K1,550 at $84.02filing
12 Aug 2026filed 13 Aug 2026DXCM DexComMedical DevicesSEC FORM 4 Code G—1,075 at $0.00filing
12 Aug 2026filed 13 Aug 2026DXCM DexComMedical DevicesSEC FORM 4 Code G—1,075 at $0.00filing
28 May 2026filed 1 Jun 2026DXCM DexComMedical DevicesSEC FORM 4 Code A—5,575 at $0.00filing
28 May 2026filed 1 Jun 2026DXCM DexComMedical DevicesSEC FORM 4 Code A—5,575 at $0.00filing
8 May 2026filed 11 May 2026DXCM DexComMedical DevicesSEC FORM 4 Code G—5,046 at $0.00filing
8 May 2026filed 11 May 2026DXCM DexComMedical DevicesSEC FORM 4 Code G—5,046 at $0.00filing
8 May 2026filed 11 May 2026DXCM DexComMedical DevicesSEC FORM 4 Code G—5,046 at $0.00filing
8 May 2026filed 11 May 2026DXCM DexComMedical DevicesSEC FORM 4 Code G—5,046 at $0.00filing
16 Jun 2025filed 17 Jun 2025DXCM DexComMedical DevicesSEC FORM 4 Sold$304K3,672 at $82.80filing
13 Jun 2025filed 17 Jun 2025DXCM DexComMedical DevicesSEC FORM 4 Sold$214K2,618 at $81.69filing
8 May 2025filed 12 May 2025DXCM DexComMedical DevicesSEC FORM 4 Code G—2,618 at $0.00filing
8 May 2025filed 12 May 2025DXCM DexComMedical DevicesSEC FORM 4 Code G—2,618 at $0.00filing
8 May 2025filed 12 May 2025DXCM DexComMedical DevicesSEC FORM 4 Code A—5,046 at $0.00filing
22 May 2024filed 24 May 2024DXCM DexComMedical DevicesSEC FORM 4 Code A—2,618 at $0.00filing
18 May 2024filed 21 May 2024DXCM DexComMedical DevicesSEC FORM 4 Code G—3,043 at $0.00filing
18 May 2024filed 21 May 2024DXCM DexComMedical DevicesSEC FORM 4 Code G—3,043 at $0.00filing

News

DexCom, Inc. $DXCM Position Lowered by Gradient Investments LLCDXCM · dailypolitical.com · 8 Oct 2026

0 headlines in the last 90 days name Nicholas Augustinos; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care21

Buys in green, sells in red, by the company’s sector.

Related people

Sadie SternEVP Chief People & Culture Off · EVP Chief People & Culture Off at Dexcom, filing Form 4 there in the last year
Michael Jon BrownEVP Chief Legal Compliance Off · EVP Chief Legal Compliance Off at Dexcom, filing Form 4 there in the last year
Jereme M. SylvainEVP, Chief Financal Officer · EVP, Chief Financal Officer at Dexcom, filing Form 4 there in the last year
Glenn S. BoehnleinDirector · Director at Dexcom, filing Form 4 there in the last year
Jacob Steven LeachPresident, CEO, and Director · President, CEO, and Director at Dexcom, filing Form 4 there in the last year
Kevin R. SayerExecutive Chair · Also traded DXCM in the last 90 days
Bridgette P. HellerDirector · Also traded DXCM in the last 90 days
Mark G. FolettaDirector · Also traded DXCM in the last 90 days